Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025)
Clinical trial NCT02007070 · COMPLETED
Trial details
- NCT number
- NCT02007070
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-28
- Primary completion
- 2015-07-09
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.